Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “outperform” rating restated by William Blair in a report released on Monday, RTT News reports. Several other equities research analysts have also recently commented on the company. Royal Bank of Canada reissued an “outperform” rating and issued a $26.00 price target on shares of Exelixis in […]
Inspire Investing LLC cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 35.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,939 shares of the biotechnology company’s stock after selling 16,729 shares during the quarter. Inspire Investing LLC’s holdings […]
Boston, January 6, 2024 On Jan. 2, barely six months after the Harvard Corporation’s fanfare announcement of political scientist Claudine Gay as the first Black woman president of Harvard, the university’s Board Fellows forced her to resign. The Corporation abruptly replaced Gay, the daughter of Haitian immigrants, with a white…
With U.S. stock markets set to open in two hours, (JNPR) was up 23.8% in pre-market trading, and (MTCH) was up 15.1%. (SRPT), (TENB), and (EXEL) were all.
Exelixis Inc. (EXEL) said it will reduce its workforce by about 175 employees or 13 percent. It expects to substantially complete the restructuring in the first quarter of 2024 and recognize a restructuring charge of approximately $25 million.